One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study

Immune activation in HIV-1-infected individuals is reduced under antiretroviral therapies, but persists, resulting in various morbidities. To better characterize this phenomenon, using a panel of 68 soluble and cell surface markers, we measured the level of activation in circulating CD4+ and CD8+ T...

Full description

Bibliographic Details
Main Authors: Christina Psomas, Mehwish Younas, Christelle Reynes, Renaud Cezar, Pierre Portalès, Edouard Tuaillon, Adeline Guigues, Corinne Merle, Nadine Atoui, Céline Fernandez, Vincent Le Moing, Claudine Barbuat, Grégory Marin, Nicolas Nagot, Albert Sotto, Jean-François Eliaou, Robert Sabatier, Jacques Reynes, Pierre Corbeau
Format: Article
Language:English
Published: Elsevier 2016-06-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396416301918
_version_ 1828530841026822144
author Christina Psomas
Mehwish Younas
Christelle Reynes
Renaud Cezar
Pierre Portalès
Edouard Tuaillon
Adeline Guigues
Corinne Merle
Nadine Atoui
Céline Fernandez
Vincent Le Moing
Claudine Barbuat
Grégory Marin
Nicolas Nagot
Albert Sotto
Jean-François Eliaou
Robert Sabatier
Jacques Reynes
Pierre Corbeau
author_facet Christina Psomas
Mehwish Younas
Christelle Reynes
Renaud Cezar
Pierre Portalès
Edouard Tuaillon
Adeline Guigues
Corinne Merle
Nadine Atoui
Céline Fernandez
Vincent Le Moing
Claudine Barbuat
Grégory Marin
Nicolas Nagot
Albert Sotto
Jean-François Eliaou
Robert Sabatier
Jacques Reynes
Pierre Corbeau
author_sort Christina Psomas
collection DOAJ
description Immune activation in HIV-1-infected individuals is reduced under antiretroviral therapies, but persists, resulting in various morbidities. To better characterize this phenomenon, using a panel of 68 soluble and cell surface markers, we measured the level of activation in circulating CD4+ and CD8+ T cells, B cells, monocytes, NK cells, polynuclear and endothelial cells as well as of inflammation and fibrinolysis in 120 virologic responders over 45 years of age. As compared with age- and sex-matched uninfected individuals, we observed a persistence of activation in all the cell subpopulations analyzed, together with marks of inflammation and fibrinolysis. Two independent hierarchical clustering analyses allowed us to identify five clusters of markers that varied concurrently, and five patient groups, each with the same activation profile. The five groups of patients could be characterized by a marker of CD4+ T cell, CD8+ T cell, NK cell, monocyte activation or of inflammation, respectively. One of these profiles was strongly associated with marks of metabolic syndrome, particularly with hyperinsulinemia (OR 12.17 [95% CI 1.79–82.86], p = 0.011). In conclusion, our study unveils biomarkers linked to metabolic syndrome that could be tested as predictive markers, and opens the way to new therapeutic approaches tailored to each patient group.
first_indexed 2024-12-11T22:29:01Z
format Article
id doaj.art-ef3beccf731a47929b3962937d9df2ae
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-12-11T22:29:01Z
publishDate 2016-06-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-ef3beccf731a47929b3962937d9df2ae2022-12-22T00:48:12ZengElsevierEBioMedicine2352-39642016-06-018C26527610.1016/j.ebiom.2016.05.008One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH studyChristina Psomas0Mehwish Younas1Christelle Reynes2Renaud Cezar3Pierre Portalès4Edouard Tuaillon5Adeline Guigues6Corinne Merle7Nadine Atoui8Céline Fernandez9Vincent Le Moing10Claudine Barbuat11Grégory Marin12Nicolas Nagot13Albert Sotto14Jean-François Eliaou15Robert Sabatier16Jacques Reynes17Pierre Corbeau18Institute for Human Genetics, CNRS UPR1142, 141 rue de la Cardonille, 34396, Montpellier cedex 5, FranceInstitute for Human Genetics, CNRS UPR1142, 141 rue de la Cardonille, 34396, Montpellier cedex 5, FranceInstitute for Functional Genomics, Montpellier University, UMR5203, 141 rue de la Cardonille, 34396 Montpellier cedex 5, FranceImmunology Department, University Hospital, Place du Pr Debré, 30029 Nîmes cedex, FranceImmunology Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceMicrobiology Department, University Hospital, 371 Av. du Doyen Gaston Giraud, 34295 Montpellier cedex 5, FranceInstitute for Human Genetics, CNRS UPR1142, 141 rue de la Cardonille, 34396, Montpellier cedex 5, FranceInfectious Diseases Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceInfectious Diseases Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceInfectious Diseases Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceInfectious Diseases Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceInfectious Diseases Department, University Hospital, Place du Pr Debré, 30029 Nîmes cedex, FranceMedical Informatics Department, University Hospital, 39 Avenue Charles Flahault, 34090 Montpellier cedex 5, FranceMedical Informatics Department, University Hospital, 39 Avenue Charles Flahault, 34090 Montpellier cedex 5, FranceMontpellier University, 5 Boulevard Henri IV, 34967 Montpellier cedex 2, FranceImmunology Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceInstitute for Functional Genomics, Montpellier University, UMR5203, 141 rue de la Cardonille, 34396 Montpellier cedex 5, FranceInfectious Diseases Department, University Hospital, 80 avenue A. Fliche, 34295 Montpellier cedex 5, FranceInstitute for Human Genetics, CNRS UPR1142, 141 rue de la Cardonille, 34396, Montpellier cedex 5, FranceImmune activation in HIV-1-infected individuals is reduced under antiretroviral therapies, but persists, resulting in various morbidities. To better characterize this phenomenon, using a panel of 68 soluble and cell surface markers, we measured the level of activation in circulating CD4+ and CD8+ T cells, B cells, monocytes, NK cells, polynuclear and endothelial cells as well as of inflammation and fibrinolysis in 120 virologic responders over 45 years of age. As compared with age- and sex-matched uninfected individuals, we observed a persistence of activation in all the cell subpopulations analyzed, together with marks of inflammation and fibrinolysis. Two independent hierarchical clustering analyses allowed us to identify five clusters of markers that varied concurrently, and five patient groups, each with the same activation profile. The five groups of patients could be characterized by a marker of CD4+ T cell, CD8+ T cell, NK cell, monocyte activation or of inflammation, respectively. One of these profiles was strongly associated with marks of metabolic syndrome, particularly with hyperinsulinemia (OR 12.17 [95% CI 1.79–82.86], p = 0.011). In conclusion, our study unveils biomarkers linked to metabolic syndrome that could be tested as predictive markers, and opens the way to new therapeutic approaches tailored to each patient group.http://www.sciencedirect.com/science/article/pii/S2352396416301918HyperinsulinemiaCell activationInflammationCoagulationEndothelium
spellingShingle Christina Psomas
Mehwish Younas
Christelle Reynes
Renaud Cezar
Pierre Portalès
Edouard Tuaillon
Adeline Guigues
Corinne Merle
Nadine Atoui
Céline Fernandez
Vincent Le Moing
Claudine Barbuat
Grégory Marin
Nicolas Nagot
Albert Sotto
Jean-François Eliaou
Robert Sabatier
Jacques Reynes
Pierre Corbeau
One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
EBioMedicine
Hyperinsulinemia
Cell activation
Inflammation
Coagulation
Endothelium
title One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
title_full One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
title_fullStr One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
title_full_unstemmed One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
title_short One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
title_sort one of the immune activation profiles observed in hiv 1 infected adults with suppressed viremia is linked to metabolic syndrome the activih study
topic Hyperinsulinemia
Cell activation
Inflammation
Coagulation
Endothelium
url http://www.sciencedirect.com/science/article/pii/S2352396416301918
work_keys_str_mv AT christinapsomas oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT mehwishyounas oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT christellereynes oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT renaudcezar oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT pierreportales oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT edouardtuaillon oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT adelineguigues oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT corinnemerle oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT nadineatoui oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT celinefernandez oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT vincentlemoing oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT claudinebarbuat oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT gregorymarin oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT nicolasnagot oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT albertsotto oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT jeanfrancoiseliaou oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT robertsabatier oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT jacquesreynes oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy
AT pierrecorbeau oneoftheimmuneactivationprofilesobservedinhiv1infectedadultswithsuppressedviremiaislinkedtometabolicsyndrometheactivihstudy